Operator instructions] As a reminder, today's conference is being recorded. I would now like to turn the conference over to the company's management. Please go ahead.Nathan Rich -- Vice President, ...

Financial writer recommends buying Elevance Health stock despite recent drop, citing strong industry trends and potential for significant upside.

Elevance Health Inc (ELV) reports robust financial performance with a focus on strategic growth and shareholder returns, ...

The company posted adjusted earnings per share of $3.84 for Q4 2024, falling short of the $3.98 consensus estimate. Revenue came in at $45 billion, slightly above the $44.9 billion analysts had ...

Elevance Health Inc. (ELV), while reporting weak fourth-quarter earnings below market estimates, on Thursday issued fiscal 2025 ...

Elevance Health, Inc. ELV reported fourth-quarter 2024 adjusted earnings per share (EPS) of $3.84, which surpassed the Zacks Consensus Estimate by 1.1%. However, the bottom line deteriorated 31.7 ...

Q4 2024 Earnings Call Transcript January 23, 2025 Elevance Health Inc. beats earnings expectations. Reported EPS is $3.84, ...

I would now like to turn the conference over to the company's management. Please go ahead. Good morning, and welcome to Elevance Health fourth-quarter 2024 earnings conference call. My name is Nathan ...

Elevance Health, Inc. ELV reported fourth-quarter 2024 adjusted earnings per share (EPS) of $3.84, which surpassed the Zacks Consensus Estimate by 1.1%. However, the bottom line deteriorated 31.7% ...

Please go ahead. Good morning, and welcome to Elevance Health's fourth quarter 2024 earnings call. My name is Nathan Rich, Vice President of Investor Relations. With us this morning on the ...